Anti-gag ribozymes

N/A

Report date: 2025/12/09 17:56:43

Base Information

Drug NameAnti-gag ribozymes
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Ribozyme
Mechanisms of ActionHIV Gag polyprotein inhibitors
TargetsHIV Gag polyprotein
Therapy Area/IndicationsLymphoma, Non-Hodgkin
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCity Of Hope National Medical CenterChildren'S Hospital Los AngelesSirna Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChironChildren'S Hospital Los AngelesMerck Sharp & Dohme Corp +[4] 
Active IndicationsN/A
Inactive IndicationsLymphoma, Non-Hodgkin

Other Information

ATC CodeN/A
Related LinksN/A